BRIEF-Catalyst Pharmaceuticals' board entered into amendment no. 1 to rights agreement
September 20, 2016 at 06:36 AM EDT
* On September 19, 2016, board unanimously approved, and entered into amendment no. 1 to rights agreement - SEC filing